P1187: END OF TREATMENT 18F FDG-PET/CT RESPONSE IS PROGNOSTIC FOR OVERALL AND PROGRESSION-FREE SURVIVAL IN PERIPHERAL T-CELL LYMPHOMA: RESULTS OF THE UK NCRI PHASE 2 RANDOMISED CHEMO-T TRIAL PET/CT SUBSTUDY. (23rd June 2022)

• Record Type: Journal Article
• Authors: Gleeson, M.; Arias, C.; Cunningham, D.; Peckitt, C.; Du, Y.; Hujairi, N.; To, Y. M.; Chen, H.-C.; Patel, S.; Chau, I.; Johnson, P.; Ardeshna, K. M.; Wotherspoon, A.; Attygalle, A.; Hawkes, E. A.; Macheta, M. P.; Collins, G. P.; Radford, J.; Forbes, A.; Hart, A.; Montoto, S.; McKay, P.; Benstead, K.; Morley, N.; Kalakonda, N.; Hasan, Y.; Turner, D.; Chua, S.
• Is Part Of: HemaSphere. Volume 6(2022)Supplement 3
• Page Start: 1073
• Page End: 1074
• Publication Date: 2022-06-23
• Subjects: Hematology -- Periodicals; 616.15005
• DOI: 10.1097/01.HS9.0000847612.86972.11
• Languages: English
• ISSNs: 2572-9241